A carregar...

A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease

The safety, tolerability, and pharmacokinetics (PKs) of bapineuzumab (AAB–001), a humanized monoclonal antibody to amyloid β, were evaluated in patients with mild-to-moderate Alzheimer disease in a phase 1, randomized, third-party unblinded, placebo-controlled, single ascending dose trial. Thirty pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Black, Ronald S., Sperling, Reisa A., Safirstein, Beth, Motter, Ruth N., Pallay, Allan, Nichols, Alice, Grundman, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715117/
https://ncbi.nlm.nih.gov/pubmed/20505438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0b013e3181c53b00
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!